127 F.Supp.2d 1085 (C.D.Cal. 2000), CV 00-00298, Motus v. Pfizer, Inc.
Linked as:
Extract
127 F.Supp.2d 1085 (C.D.Cal. 2000), CV 00-00298, Motus v. Pfizer, Inc.
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Requirements on content and format of labeling for human prescription drug and biological products
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products described in section 201.56(b)(1)
- Code of Federal Regulations - Supplements and other changes to an approved NDA
- Code of Federal Regulations - Changes to an approved application
- US Code - 21 U.S.C. § 393 Food and Drug Administration
